🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Objective To evaluate whether Xingnaojing injection combined with Naoxueshu...
Status
Unknown
Location
Peking Yniversity Third Hospital
Start Date
2019-06-01
Trial ID
NCT04946474
Treatments Being Tested
The main purpose of this trial is to observe whether Xingnaojing, intraveno...
Status
Unknown
Location
Dongzhimen Hospital
Start Date
2020-03-20
Trial ID
NCT04275349
Treatments Being Tested
The main purpose of this trial is to determine whether Xingnaojing, intrave...
Status
Unknown
Location
Dongzhimen Hospital
Start Date
2020-03-19
Trial ID
NCT04150835
Treatments Being Tested
The main purpose of this trial is to analyse the Effects of Xingnaojing for...
Status
Unknown
Location
Dongzhimen Hospital
Start Date
2021-05-28
Trial ID
NCT04813445
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of Xingnaojing for th...
Status
Unknown
Location
Multiple Locations
Start Date
2008-12
Trial ID
NCT00796380
Treatments Being Tested
The purpose of this study is to investigate the effect of tDCS stimulation ...
Status
Not Yet Recruiting
Location
Electroencephalography
Start Date
2025-04-25
Trial ID
NCT06927336
Treatments Being Tested
The main purposes of this trial are to analyze the pharmacodynamic substanc...
Status
Unknown
Location
Beijing Chaoyang Integrative Medicine Rescue and First Aid Hospital
Start Date
2022-08-16
Trial ID
NCT05559307
Treatments Being Tested
The main purpose of this study is to determine whether deferoxamine and xin...
Status
Unknown
Location
Department of Neurology，Beijing Shijitan Hospital，Capital Medical University
Start Date
2015-03
Trial ID
NCT02367248
Treatments Being Tested
The main purpose of this trial is to determine whether Xingnaojing, intrave...
Status
Unknown
Location
Dongzhimen Hospital
Start Date
2016-03
Trial ID
NCT02728180
Treatments Being Tested